Feb 17 (Reuters) - Nuvo Research Inc NRI.TO :
* Research announces 2015 fourth quarter & year-end results
* Qtrly earnings per share $0.03
* Q4 total revenue was $7.8 million compared to $3.4 million for the three
months ended December 31, 2014
* In February 2016, nuvo's board unanimously approved proposal to initiate
divestiture or orderly wind down of immunology group
* Continues to explore possible sale of immunology group
* If divestiture transaction does not materialize, wind down of immunology
operations is expected to be completed by end of 2016
* Source text for Eikon ID:nCNW8kkyVa
* Further company coverage NRI.TO